Dopamine beta-hydroxylase
Dopamine beta-hydroxylase (DBH), also known as dopamine beta-monooxygenase, is an enzyme that catalyzes the conversion of dopamine to norepinephrine.
Function[edit | edit source]
DBH is a copper-containing oxygenase that exists as a tetramer with four identical subunits. It is located in the synaptic vesicles of postganglionic sympathetic neurons and in adrenal medulla, where it converts dopamine to norepinephrine. This conversion is a critical step in the sympathetic nervous system's production of norepinephrine, which plays a key role in the body's fight or flight response.
Clinical significance[edit | edit source]
Mutations in the DBH gene can lead to Dopamine beta hydroxylase deficiency, a condition characterized by a lack of norepinephrine and epinephrine in patients. Symptoms can include orthostatic hypotension, ptosis, and nasal stuffiness.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Dopamine beta-hydroxylase Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD